The global market for Sleeping Pills (Prescription Drugs) was valued at US$ 1077 million in the year 2024 and is projected to reach a revised size of US$ 1502 million by 2031, growing at a CAGR of 4.9% during the forecast period.

Sleeping Pills (Prescription Drugs) Market

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Sleeping Pills (Prescription Drugs), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sleeping Pills (Prescription Drugs).

The Sleeping Pills (Prescription Drugs) market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Sleeping Pills (Prescription Drugs) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Sleeping Pills (Prescription Drugs) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Sleeping Pills (Prescription Drugs) Market Report

Report Metric	Details
Report Name	Sleeping Pills (Prescription Drugs) Market
Accounted market size in year	US$ 1077 million
Forecasted market size in 2031	US$ 1502 million
CAGR	4.9%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Zolpidem Eszopiclone (Lunesta) Ramelteon (Rozerem) Ativan (lorazepam) Adapin (doxepin)
Segment by Application	Hospital Pharmacy Retail Pharmacy
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Sanofi, Abbott Laboratories, Takeda Pharmaceutical, Apotex, Aurobindo Pharma, Actellon Pharmaceuticals, Allegiant Health, Cayman Chemical, Ambitropin, Hayao
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Sleeping Pills (Prescription Drugs) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Sleeping Pills (Prescription Drugs) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Sleeping Pills (Prescription Drugs) Market growing?

Ans: The Sleeping Pills (Prescription Drugs) Market witnessing a CAGR of 4.9% during the forecast period 2025-2031.

What is the Sleeping Pills (Prescription Drugs) Market size in 2031?

Ans: The Sleeping Pills (Prescription Drugs) Market size in 2031 will be US$ 1502 million.

Who are the main players in the Sleeping Pills (Prescription Drugs) Market report?

Ans: The main players in the Sleeping Pills (Prescription Drugs) Market are Sanofi, Abbott Laboratories, Takeda Pharmaceutical, Apotex, Aurobindo Pharma, Actellon Pharmaceuticals, Allegiant Health, Cayman Chemical, Ambitropin, Hayao

What are the Application segmentation covered in the Sleeping Pills (Prescription Drugs) Market report?

Ans: The Applications covered in the Sleeping Pills (Prescription Drugs) Market report are Hospital Pharmacy, Retail Pharmacy

What are the Type segmentation covered in the Sleeping Pills (Prescription Drugs) Market report?

Ans: The Types covered in the Sleeping Pills (Prescription Drugs) Market report are Zolpidem, Eszopiclone (Lunesta), Ramelteon (Rozerem), Ativan (lorazepam), Adapin (doxepin)

1 Sleeping Pills (Prescription Drugs) Market Overview

1.1 Product Definition

1.2 Sleeping Pills (Prescription Drugs) by Type

1.2.1 Global Sleeping Pills (Prescription Drugs) Market Value Comparison by Type (2024 VS 2031)

1.2.2 Zolpidem

1.2.3 Eszopiclone (Lunesta)

1.2.4 Ramelteon (Rozerem)

1.2.5 Ativan (lorazepam)

1.2.6 Adapin (doxepin)

1.3 Sleeping Pills (Prescription Drugs) by Application

1.3.1 Global Sleeping Pills (Prescription Drugs) Market Value by Application (2024 VS 2031)

1.3.2 Hospital Pharmacy

1.3.3 Retail Pharmacy

1.4 Global Sleeping Pills (Prescription Drugs) Market Size Estimates and Forecasts

1.4.1 Global Sleeping Pills (Prescription Drugs) Revenue 2020-2031

1.4.2 Global Sleeping Pills (Prescription Drugs) Sales 2020-2031

1.4.3 Global Sleeping Pills (Prescription Drugs) Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Sleeping Pills (Prescription Drugs) Market Competition by Manufacturers

2.1 Global Sleeping Pills (Prescription Drugs) Sales Market Share by Manufacturers (2020-2025)

2.2 Global Sleeping Pills (Prescription Drugs) Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Sleeping Pills (Prescription Drugs) Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Sleeping Pills (Prescription Drugs), Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Sleeping Pills (Prescription Drugs), Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Sleeping Pills (Prescription Drugs), Product Type & Application

2.7 Global Key Manufacturers of Sleeping Pills (Prescription Drugs), Date of Enter into This Industry

2.8 Global Sleeping Pills (Prescription Drugs) Market Competitive Situation and Trends

2.8.1 Global Sleeping Pills (Prescription Drugs) Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Sleeping Pills (Prescription Drugs) Players Market Share by Revenue

2.8.3 Global Sleeping Pills (Prescription Drugs) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Sleeping Pills (Prescription Drugs) Market Scenario by Region

3.1 Global Sleeping Pills (Prescription Drugs) Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Sleeping Pills (Prescription Drugs) Sales by Region: 2020-2031

3.2.1 Global Sleeping Pills (Prescription Drugs) Sales by Region: 2020-2025

3.2.2 Global Sleeping Pills (Prescription Drugs) Sales by Region: 2026-2031

3.3 Global Sleeping Pills (Prescription Drugs) Revenue by Region: 2020-2031

3.3.1 Global Sleeping Pills (Prescription Drugs) Revenue by Region: 2020-2025

3.3.2 Global Sleeping Pills (Prescription Drugs) Revenue by Region: 2026-2031

3.4 North America Sleeping Pills (Prescription Drugs) Market Facts & Figures by Country

3.4.1 North America Sleeping Pills (Prescription Drugs) Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Sleeping Pills (Prescription Drugs) Sales by Country (2020-2031)

3.4.3 North America Sleeping Pills (Prescription Drugs) Revenue by Country (2020-2031)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Sleeping Pills (Prescription Drugs) Market Facts & Figures by Country

3.5.1 Europe Sleeping Pills (Prescription Drugs) Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Sleeping Pills (Prescription Drugs) Sales by Country (2020-2031)

3.5.3 Europe Sleeping Pills (Prescription Drugs) Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Sleeping Pills (Prescription Drugs) Market Facts & Figures by Region

3.6.1 Asia Pacific Sleeping Pills (Prescription Drugs) Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Sleeping Pills (Prescription Drugs) Sales by Region (2020-2031)

3.6.3 Asia Pacific Sleeping Pills (Prescription Drugs) Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Sleeping Pills (Prescription Drugs) Market Facts & Figures by Country

3.7.1 Latin America Sleeping Pills (Prescription Drugs) Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Sleeping Pills (Prescription Drugs) Sales by Country (2020-2031)

3.7.3 Latin America Sleeping Pills (Prescription Drugs) Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Sleeping Pills (Prescription Drugs) Market Facts & Figures by Country

3.8.1 Middle East and Africa Sleeping Pills (Prescription Drugs) Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Sleeping Pills (Prescription Drugs) Sales by Country (2020-2031)

3.8.3 Middle East and Africa Sleeping Pills (Prescription Drugs) Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 U.A.E

4 Segment by Type

4.1 Global Sleeping Pills (Prescription Drugs) Sales by Type (2020-2031)

4.1.1 Global Sleeping Pills (Prescription Drugs) Sales by Type (2020-2025)

4.1.2 Global Sleeping Pills (Prescription Drugs) Sales by Type (2026-2031)

4.1.3 Global Sleeping Pills (Prescription Drugs) Sales Market Share by Type (2020-2031)

4.2 Global Sleeping Pills (Prescription Drugs) Revenue by Type (2020-2031)

4.2.1 Global Sleeping Pills (Prescription Drugs) Revenue by Type (2020-2025)

4.2.2 Global Sleeping Pills (Prescription Drugs) Revenue by Type (2026-2031)

4.2.3 Global Sleeping Pills (Prescription Drugs) Revenue Market Share by Type (2020-2031)

4.3 Global Sleeping Pills (Prescription Drugs) Price by Type (2020-2031)

5 Segment by Application

5.1 Global Sleeping Pills (Prescription Drugs) Sales by Application (2020-2031)

5.1.1 Global Sleeping Pills (Prescription Drugs) Sales by Application (2020-2025)

5.1.2 Global Sleeping Pills (Prescription Drugs) Sales by Application (2026-2031)

5.1.3 Global Sleeping Pills (Prescription Drugs) Sales Market Share by Application (2020-2031)

5.2 Global Sleeping Pills (Prescription Drugs) Revenue by Application (2020-2031)

5.2.1 Global Sleeping Pills (Prescription Drugs) Revenue by Application (2020-2025)

5.2.2 Global Sleeping Pills (Prescription Drugs) Revenue by Application (2026-2031)

5.2.3 Global Sleeping Pills (Prescription Drugs) Revenue Market Share by Application (2020-2031)

5.3 Global Sleeping Pills (Prescription Drugs) Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Sanofi

6.1.1 Sanofi Company Information

6.1.2 Sanofi Description and Business Overview

6.1.3 Sanofi Sleeping Pills (Prescription Drugs) Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Sanofi Sleeping Pills (Prescription Drugs) Product Portfolio

6.1.5 Sanofi Recent Developments/Updates

6.2 Abbott Laboratories

6.2.1 Abbott Laboratories Company Information

6.2.2 Abbott Laboratories Description and Business Overview

6.2.3 Abbott Laboratories Sleeping Pills (Prescription Drugs) Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Abbott Laboratories Sleeping Pills (Prescription Drugs) Product Portfolio

6.2.5 Abbott Laboratories Recent Developments/Updates

6.3 Takeda Pharmaceutical

6.3.1 Takeda Pharmaceutical Company Information

6.3.2 Takeda Pharmaceutical Description and Business Overview

6.3.3 Takeda Pharmaceutical Sleeping Pills (Prescription Drugs) Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Takeda Pharmaceutical Sleeping Pills (Prescription Drugs) Product Portfolio

6.3.5 Takeda Pharmaceutical Recent Developments/Updates

6.4 Apotex

6.4.1 Apotex Company Information

6.4.2 Apotex Description and Business Overview

6.4.3 Apotex Sleeping Pills (Prescription Drugs) Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Apotex Sleeping Pills (Prescription Drugs) Product Portfolio

6.4.5 Apotex Recent Developments/Updates

6.5 Aurobindo Pharma

6.5.1 Aurobindo Pharma Company Information

6.5.2 Aurobindo Pharma Description and Business Overview

6.5.3 Aurobindo Pharma Sleeping Pills (Prescription Drugs) Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Aurobindo Pharma Sleeping Pills (Prescription Drugs) Product Portfolio

6.5.5 Aurobindo Pharma Recent Developments/Updates

6.6 Actellon Pharmaceuticals

6.6.1 Actellon Pharmaceuticals Company Information

6.6.2 Actellon Pharmaceuticals Description and Business Overview

6.6.3 Actellon Pharmaceuticals Sleeping Pills (Prescription Drugs) Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Actellon Pharmaceuticals Sleeping Pills (Prescription Drugs) Product Portfolio

6.6.5 Actellon Pharmaceuticals Recent Developments/Updates

6.7 Allegiant Health

6.7.1 Allegiant Health Company Information

6.7.2 Allegiant Health Description and Business Overview

6.7.3 Allegiant Health Sleeping Pills (Prescription Drugs) Sales, Revenue and Gross Margin (2020-2025)

6.7.4 Allegiant Health Sleeping Pills (Prescription Drugs) Product Portfolio

6.7.5 Allegiant Health Recent Developments/Updates

6.8 Cayman Chemical

6.8.1 Cayman Chemical Company Information

6.8.2 Cayman Chemical Description and Business Overview

6.8.3 Cayman Chemical Sleeping Pills (Prescription Drugs) Sales, Revenue and Gross Margin (2020-2025)

6.8.4 Cayman Chemical Sleeping Pills (Prescription Drugs) Product Portfolio

6.8.5 Cayman Chemical Recent Developments/Updates

6.9 Ambitropin

6.9.1 Ambitropin Company Information

6.9.2 Ambitropin Description and Business Overview

6.9.3 Ambitropin Sleeping Pills (Prescription Drugs) Sales, Revenue and Gross Margin (2020-2025)

6.9.4 Ambitropin Sleeping Pills (Prescription Drugs) Product Portfolio

6.9.5 Ambitropin Recent Developments/Updates

6.10 Hayao

6.10.1 Hayao Company Information

6.10.2 Hayao Description and Business Overview

6.10.3 Hayao Sleeping Pills (Prescription Drugs) Sales, Revenue and Gross Margin (2020-2025)

6.10.4 Hayao Sleeping Pills (Prescription Drugs) Product Portfolio

6.10.5 Hayao Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Sleeping Pills (Prescription Drugs) Industry Chain Analysis

7.2 Sleeping Pills (Prescription Drugs) Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Sleeping Pills (Prescription Drugs) Production Mode & Process Analysis

7.4 Sleeping Pills (Prescription Drugs) Sales and Marketing

7.4.1 Sleeping Pills (Prescription Drugs) Sales Channels

7.4.2 Sleeping Pills (Prescription Drugs) Distributors

7.5 Sleeping Pills (Prescription Drugs) Customer Analysis

8 Sleeping Pills (Prescription Drugs) Market Dynamics

8.1 Sleeping Pills (Prescription Drugs) Industry Trends

8.2 Sleeping Pills (Prescription Drugs) Market Drivers

8.3 Sleeping Pills (Prescription Drugs) Market Challenges

8.4 Sleeping Pills (Prescription Drugs) Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Sanofi

Abbott Laboratories

Takeda Pharmaceutical

Apotex

Aurobindo Pharma

Actellon Pharmaceuticals

List of Tables

Table 1. Global Sleeping Pills (Prescription Drugs) Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Sleeping Pills (Prescription Drugs) Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Sleeping Pills (Prescription Drugs) Market Competitive Situation by Manufacturers in 2024

Table 4. Global Sleeping Pills (Prescription Drugs) Sales (K Units) of Key Manufacturers (2020-2025)

Table 5. Global Sleeping Pills (Prescription Drugs) Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Sleeping Pills (Prescription Drugs) Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Sleeping Pills (Prescription Drugs) Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Sleeping Pills (Prescription Drugs) Average Price (USD/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Sleeping Pills (Prescription Drugs), Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Sleeping Pills (Prescription Drugs), Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Sleeping Pills (Prescription Drugs), Product Type & Application

Table 12. Global Key Manufacturers of Sleeping Pills (Prescription Drugs), Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Sleeping Pills (Prescription Drugs) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sleeping Pills (Prescription Drugs) as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Sleeping Pills (Prescription Drugs) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Sleeping Pills (Prescription Drugs) Sales by Region (2020-2025) & (K Units)

Table 18. Global Sleeping Pills (Prescription Drugs) Sales Market Share by Region (2020-2025)

Table 19. Global Sleeping Pills (Prescription Drugs) Sales by Region (2026-2031) & (K Units)

Table 20. Global Sleeping Pills (Prescription Drugs) Sales Market Share by Region (2026-2031)

Table 21. Global Sleeping Pills (Prescription Drugs) Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Sleeping Pills (Prescription Drugs) Revenue Market Share by Region (2020-2025)

Table 23. Global Sleeping Pills (Prescription Drugs) Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Sleeping Pills (Prescription Drugs) Revenue Market Share by Region (2026-2031)

Table 25. North America Sleeping Pills (Prescription Drugs) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Sleeping Pills (Prescription Drugs) Sales by Country (2020-2025) & (K Units)

Table 27. North America Sleeping Pills (Prescription Drugs) Sales by Country (2026-2031) & (K Units)

Table 28. North America Sleeping Pills (Prescription Drugs) Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Sleeping Pills (Prescription Drugs) Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Sleeping Pills (Prescription Drugs) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Sleeping Pills (Prescription Drugs) Sales by Country (2020-2025) & (K Units)

Table 32. Europe Sleeping Pills (Prescription Drugs) Sales by Country (2026-2031) & (K Units)

Table 33. Europe Sleeping Pills (Prescription Drugs) Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Sleeping Pills (Prescription Drugs) Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Sleeping Pills (Prescription Drugs) Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Sleeping Pills (Prescription Drugs) Sales by Region (2020-2025) & (K Units)

Table 37. Asia Pacific Sleeping Pills (Prescription Drugs) Sales by Region (2026-2031) & (K Units)

Table 38. Asia Pacific Sleeping Pills (Prescription Drugs) Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Sleeping Pills (Prescription Drugs) Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Sleeping Pills (Prescription Drugs) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Sleeping Pills (Prescription Drugs) Sales by Country (2020-2025) & (K Units)

Table 42. Latin America Sleeping Pills (Prescription Drugs) Sales by Country (2026-2031) & (K Units)

Table 43. Latin America Sleeping Pills (Prescription Drugs) Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Sleeping Pills (Prescription Drugs) Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Sleeping Pills (Prescription Drugs) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Sleeping Pills (Prescription Drugs) Sales by Country (2020-2025) & (K Units)

Table 47. Middle East and Africa Sleeping Pills (Prescription Drugs) Sales by Country (2026-2031) & (K Units)

Table 48. Middle East and Africa Sleeping Pills (Prescription Drugs) Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Sleeping Pills (Prescription Drugs) Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Sleeping Pills (Prescription Drugs) Sales (K Units) by Type (2020-2025)

Table 51. Global Sleeping Pills (Prescription Drugs) Sales (K Units) by Type (2026-2031)

Table 52. Global Sleeping Pills (Prescription Drugs) Sales Market Share by Type (2020-2025)

Table 53. Global Sleeping Pills (Prescription Drugs) Sales Market Share by Type (2026-2031)

Table 54. Global Sleeping Pills (Prescription Drugs) Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Sleeping Pills (Prescription Drugs) Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Sleeping Pills (Prescription Drugs) Revenue Market Share by Type (2020-2025)

Table 57. Global Sleeping Pills (Prescription Drugs) Revenue Market Share by Type (2026-2031)

Table 58. Global Sleeping Pills (Prescription Drugs) Price (USD/Unit) by Type (2020-2025)

Table 59. Global Sleeping Pills (Prescription Drugs) Price (USD/Unit) by Type (2026-2031)

Table 60. Global Sleeping Pills (Prescription Drugs) Sales (K Units) by Application (2020-2025)

Table 61. Global Sleeping Pills (Prescription Drugs) Sales (K Units) by Application (2026-2031)

Table 62. Global Sleeping Pills (Prescription Drugs) Sales Market Share by Application (2020-2025)

Table 63. Global Sleeping Pills (Prescription Drugs) Sales Market Share by Application (2026-2031)

Table 64. Global Sleeping Pills (Prescription Drugs) Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Sleeping Pills (Prescription Drugs) Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Sleeping Pills (Prescription Drugs) Revenue Market Share by Application (2020-2025)

Table 67. Global Sleeping Pills (Prescription Drugs) Revenue Market Share by Application (2026-2031)

Table 68. Global Sleeping Pills (Prescription Drugs) Price (USD/Unit) by Application (2020-2025)

Table 69. Global Sleeping Pills (Prescription Drugs) Price (USD/Unit) by Application (2026-2031)

Table 70. Sanofi Company Information

Table 71. Sanofi Description and Business Overview

Table 72. Sanofi Sleeping Pills (Prescription Drugs) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 73. Sanofi Sleeping Pills (Prescription Drugs) Product

Table 74. Sanofi Recent Developments/Updates

Table 75. Abbott Laboratories Company Information

Table 76. Abbott Laboratories Description and Business Overview

Table 77. Abbott Laboratories Sleeping Pills (Prescription Drugs) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 78. Abbott Laboratories Sleeping Pills (Prescription Drugs) Product

Table 79. Abbott Laboratories Recent Developments/Updates

Table 80. Takeda Pharmaceutical Company Information

Table 81. Takeda Pharmaceutical Description and Business Overview

Table 82. Takeda Pharmaceutical Sleeping Pills (Prescription Drugs) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 83. Takeda Pharmaceutical Sleeping Pills (Prescription Drugs) Product

Table 84. Takeda Pharmaceutical Recent Developments/Updates

Table 85. Apotex Company Information

Table 86. Apotex Description and Business Overview

Table 87. Apotex Sleeping Pills (Prescription Drugs) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 88. Apotex Sleeping Pills (Prescription Drugs) Product

Table 89. Apotex Recent Developments/Updates

Table 90. Aurobindo Pharma Company Information

Table 91. Aurobindo Pharma Description and Business Overview

Table 92. Aurobindo Pharma Sleeping Pills (Prescription Drugs) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 93. Aurobindo Pharma Sleeping Pills (Prescription Drugs) Product

Table 94. Aurobindo Pharma Recent Developments/Updates

Table 95. Actellon Pharmaceuticals Company Information

Table 96. Actellon Pharmaceuticals Description and Business Overview

Table 97. Actellon Pharmaceuticals Sleeping Pills (Prescription Drugs) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 98. Actellon Pharmaceuticals Sleeping Pills (Prescription Drugs) Product

Table 99. Actellon Pharmaceuticals Recent Developments/Updates

Table 100. Allegiant Health Company Information

Table 101. Allegiant Health Description and Business Overview

Table 102. Allegiant Health Sleeping Pills (Prescription Drugs) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 103. Allegiant Health Sleeping Pills (Prescription Drugs) Product

Table 104. Allegiant Health Recent Developments/Updates

Table 105. Cayman Chemical Company Information

Table 106. Cayman Chemical Description and Business Overview

Table 107. Cayman Chemical Sleeping Pills (Prescription Drugs) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 108. Cayman Chemical Sleeping Pills (Prescription Drugs) Product

Table 109. Cayman Chemical Recent Developments/Updates

Table 110. Ambitropin Company Information

Table 111. Ambitropin Description and Business Overview

Table 112. Ambitropin Sleeping Pills (Prescription Drugs) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 113. Ambitropin Sleeping Pills (Prescription Drugs) Product

Table 114. Ambitropin Recent Developments/Updates

Table 115. Hayao Company Information

Table 116. Hayao Description and Business Overview

Table 117. Hayao Sleeping Pills (Prescription Drugs) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 118. Hayao Sleeping Pills (Prescription Drugs) Product

Table 119. Hayao Recent Developments/Updates

Table 120. Key Raw Materials Lists

Table 121. Raw Materials Key Suppliers Lists

Table 122. Sleeping Pills (Prescription Drugs) Distributors List

Table 123. Sleeping Pills (Prescription Drugs) Customers List

Table 124. Sleeping Pills (Prescription Drugs) Market Trends

Table 125. Sleeping Pills (Prescription Drugs) Market Drivers

Table 126. Sleeping Pills (Prescription Drugs) Market Challenges

Table 127. Sleeping Pills (Prescription Drugs) Market Restraints

Table 128. Research Programs/Design for This Report

Table 129. Key Data Information from Secondary Sources

Table 130. Key Data Information from Primary Sources

Table 131. Authors List of This Report

List of Figures

Figure 1. Product Picture of Sleeping Pills (Prescription Drugs)

Figure 2. Global Sleeping Pills (Prescription Drugs) Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Sleeping Pills (Prescription Drugs) Market Share by Type: 2024 & 2031

Figure 4. Zolpidem Product Picture

Figure 5. Eszopiclone (Lunesta) Product Picture

Figure 6. Ramelteon (Rozerem) Product Picture

Figure 7. Ativan (lorazepam) Product Picture

Figure 8. Adapin (doxepin) Product Picture

Figure 9. Global Sleeping Pills (Prescription Drugs) Market Value by Application (2020-2031) & (US$ Million)

Figure 10. Global Sleeping Pills (Prescription Drugs) Market Share by Application: 2024 & 2031

Figure 11. Hospital Pharmacy

Figure 12. Retail Pharmacy

Figure 13. Global Sleeping Pills (Prescription Drugs) Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global Sleeping Pills (Prescription Drugs) Market Size (2020-2031) & (US$ Million)

Figure 15. Global Sleeping Pills (Prescription Drugs) Sales (2020-2031) & (K Units)

Figure 16. Global Sleeping Pills (Prescription Drugs) Average Price (USD/Unit) & (2020-2031)

Figure 17. Sleeping Pills (Prescription Drugs) Report Years Considered

Figure 18. Sleeping Pills (Prescription Drugs) Sales Share by Manufacturers in 2024

Figure 19. Global Sleeping Pills (Prescription Drugs) Revenue Share by Manufacturers in 2024

Figure 20. Global 5 and 10 Largest Sleeping Pills (Prescription Drugs) Players: Market Share by Revenue in Sleeping Pills (Prescription Drugs) in 2024

Figure 21. Sleeping Pills (Prescription Drugs) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 22. Global Sleeping Pills (Prescription Drugs) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 23. North America Sleeping Pills (Prescription Drugs) Sales Market Share by Country (2020-2031)

Figure 24. North America Sleeping Pills (Prescription Drugs) Revenue Market Share by Country (2020-2031)

Figure 25. U.S. Sleeping Pills (Prescription Drugs) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 26. Canada Sleeping Pills (Prescription Drugs) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 27. Europe Sleeping Pills (Prescription Drugs) Sales Market Share by Country (2020-2031)

Figure 28. Europe Sleeping Pills (Prescription Drugs) Revenue Market Share by Country (2020-2031)

Figure 29. Germany Sleeping Pills (Prescription Drugs) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. France Sleeping Pills (Prescription Drugs) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. U.K. Sleeping Pills (Prescription Drugs) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. Italy Sleeping Pills (Prescription Drugs) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 33. Russia Sleeping Pills (Prescription Drugs) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 34. Asia Pacific Sleeping Pills (Prescription Drugs) Sales Market Share by Region (2020-2031)

Figure 35. Asia Pacific Sleeping Pills (Prescription Drugs) Revenue Market Share by Region (2020-2031)

Figure 36. China Sleeping Pills (Prescription Drugs) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. Japan Sleeping Pills (Prescription Drugs) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. South Korea Sleeping Pills (Prescription Drugs) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. India Sleeping Pills (Prescription Drugs) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. Australia Sleeping Pills (Prescription Drugs) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Taiwan Sleeping Pills (Prescription Drugs) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. Indonesia Sleeping Pills (Prescription Drugs) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. Thailand Sleeping Pills (Prescription Drugs) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. Malaysia Sleeping Pills (Prescription Drugs) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. Philippines Sleeping Pills (Prescription Drugs) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 46. Latin America Sleeping Pills (Prescription Drugs) Sales Market Share by Country (2020-2031)

Figure 47. Latin America Sleeping Pills (Prescription Drugs) Revenue Market Share by Country (2020-2031)

Figure 48. Mexico Sleeping Pills (Prescription Drugs) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 49. Brazil Sleeping Pills (Prescription Drugs) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 50. Argentina Sleeping Pills (Prescription Drugs) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 51. Middle East and Africa Sleeping Pills (Prescription Drugs) Sales Market Share by Country (2020-2031)

Figure 52. Middle East and Africa Sleeping Pills (Prescription Drugs) Revenue Market Share by Country (2020-2031)

Figure 53. Turkey Sleeping Pills (Prescription Drugs) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 54. Saudi Arabia Sleeping Pills (Prescription Drugs) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 55. U.A.E Sleeping Pills (Prescription Drugs) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 56. Global Sales Market Share of Sleeping Pills (Prescription Drugs) by Type (2020-2031)

Figure 57. Global Revenue Market Share of Sleeping Pills (Prescription Drugs) by Type (2020-2031)

Figure 58. Global Sleeping Pills (Prescription Drugs) Price (USD/Unit) by Type (2020-2031)

Figure 59. Global Sales Market Share of Sleeping Pills (Prescription Drugs) by Application (2020-2031)

Figure 60. Global Revenue Market Share of Sleeping Pills (Prescription Drugs) by Application (2020-2031)

Figure 61. Global Sleeping Pills (Prescription Drugs) Price (USD/Unit) by Application (2020-2031)

Figure 62. Sleeping Pills (Prescription Drugs) Value Chain

Figure 63. Channels of Distribution (Direct Vs Distribution)

Figure 64. Bottom-up and Top-down Approaches for This Report

Figure 65. Data Triangulation

Figure 66. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Sodium Picosulfate Oral Drug Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-14H19081

Mon Feb 17 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

Global Intrathecal Drug Pump Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-7E13922

Mon Feb 17 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

Global Algae Omega3 Ingredient Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-22X3084

Mon Feb 17 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

Global Animal Immunoglobulin Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-6Q19165

Mon Feb 17 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions